![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 04, 2015 12:11:15 PM
The thing I liked was, initial stocking was likely only for 4/6 weeks which likely means more Glatopa reorders coming up as we are six weeks out. We need to crank sales up now to cover the 35/40M per quarterly expenses. The wholesalers are not carrying large inventories.
They indicated there was quite extremely positive feedback overall and strong demand from wholesalers.
Most any other stock would have got a big bump with our exceeding numbers today.
They sounded very positive on the potential for expansion of our drug to use for many other cancers with our current cancer trial.
Sounded fairly confident the 40MG Glatopa dosage should proceed fairly fast with the FDA.
Talking to quite a few people on a broad agreement on 7 bio similar. Should know 2nd half if a broad agreement or several smaller agreements. There are discussions going on from both fronts.
Boing X 2
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM